Diethyl Hydrogen Phosphate

Diethyl Hydrogen Phosphate

SCHEMBL2447154

C#N.CCOP(=O)(O)OCC

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
PPARD Q03181 2/20 0.46
TP53 P04637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ACHE P22303 1/20 0.38
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
LPAR1 Q92633 2/20 0.34
LPAR3 Q9UBY5 2/20 0.34
LPAR2 Q9HBW0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethyl Hydrogen Phosphate SCHEMBL27405765 0.92 TSHR (0.50) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL93056 0.91
Diethyl Hydrogen Phosphate SCHEMBL27294237 0.91 TSHR (0.56) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL17008846 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL3133022 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL4948463 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL11745053 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL6694735 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL11752938 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL8431810 0.88 TSHR (0.53) TSHRPPARDTP53TDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3109393-A None JP disclosed
JP-3106896-A None JP disclosed
JP-58113198-A None JP disclosed
JP-61151199-A None JP disclosed
US-20240399299-A1 Gas Separation Membrane And Method For Manufacturing Gas Separation Membrane SEIKO EPSON CORPORATION (JP) 2024-12-05 US disclosed
EP-4470654-A2 GAS SEPARATION MEMBRANE AND METHOD FOR MANUFACTURING GAS SEPARATION MEMBRANE Seiko Epson Corporation (JP) 2024-12-04 EP disclosed
US-20240294497-A1 METHOD FOR PRODUCING MONOCYCLIC PYRIDINE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-09-05 US disclosed
EP-4361143-A1 METHOD FOR PRODUCING MONOCYCLIC PYRIDINE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2024-05-01 EP disclosed
WO-2020189557-A1 POLYIMIDE FILM 三菱ケミカル株式会社 2020-09-24 WO disclosed
WO-2020189556-A1 POLYIMIDE FILM 三菱ケミカル株式会社 2020-09-24 WO disclosed
US-5344928-A Phenothiazine compounds for cancer treatment or immunoassay using chemiluminescence TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-09-06 US disclosed
EP-0543997-A1 NOVEL METHOTREXATE DERIVATIVE Chugai Seiyaku Kabushiki Kaisha (JP) 1993-06-02 EP disclosed
EP-0510668-A2 Phenothiazine derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-10-28 EP disclosed
US-5036065-A Antiarrythmic agents, anesthetics, calcium antagonists TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1991-07-30 US disclosed
JP-H03109393-A CARBOXYLIC AMIDE DERIVATIVE OTSUKA PHARMACEUT FACTORY INC 1991-05-09 JP disclosed
JP-H03106896-A 30-SUBSTITUTED GLYCYRRHIZIN DERIVATIVE AND LIPOSOME PREPARATION CONTAINING THE SAME AS FILM-FORMING COMPONENT TAIHO YAKUHIN KOGYO KK 1991-05-07 JP disclosed
EP-0394484-A1 BENZOTHIADIAZEPINE DERIVATIVES TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1990-10-31 EP disclosed
JP-S61151199-A CARBOXYLIC ACID AMIDE DERIVATIVE OTSUKA PHARMACEUT FACTORY INC 1986-07-09 JP disclosed
JP-S58113198-A PORPHYRIN COMPOUND BONDED WITH CYCLODEXTRIN TSUCHIDA HIDETOSHI 1983-07-05 JP disclosed
US-4229573-A BACTERICIDES ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1980-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294497-A1 METHOD FOR PRODUCING MONOCYCLIC PYRIDINE DERIVATIVE BRD7, SIRT7, PRDM7 TSHR 3547/4885PPARD 1032/4885TP53 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.